Previous Article | Next Article 
Molecular and Cellular Biology, October 1999, p. 6632-6641, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
RBP1 Recruits Both Histone Deacetylase-Dependent
and -Independent Repression Activities to Retinoblastoma
Family Proteins
Albert
Lai,1
Joseph M.
Lee,1
Wen-Ming
Yang,2
James A.
DeCaprio,3
William G.
Kaelin Jr.,3,4
Edward
Seto,2 and
Philip E.
Branton1,5,*
Departments of
Biochemistry1 and
Oncology,5 McGill University, Montreal,
Quebec, Canada H3G 1Y6; H. Lee Moffitt Cancer Center and
Research Institute, Molecular Oncology Program, University of South
Florida, Tampa, Florida 336122; and
Dana-Farber Cancer Institute and Harvard Medical
School3 and Howard Hughes Medical
Institute,4 Boston, Massachusetts 02115
Received 3 May 1999/Returned for modification 1 June 1999/Accepted 18 June 1999
 |
ABSTRACT |
Retinoblastoma (RB) tumor suppressor family proteins block cell
proliferation in part by repressing certain E2F-specific promoters. Both histone deacetylase (HDAC)-dependent and -independent repression activities are associated with the RB "pocket." The mechanism by
which these two repression functions occupy the pocket is unknown. A
known RB-binding protein, RBP1, was previously found by our group to be
an active corepressor which, if overexpressed, represses E2F-mediated
transcription via its association with the pocket. We show here that
RBP1 contains two repression domains, one of which binds all three
known HDACs and represses them in an HDAC-dependent manner while the
other domain functions independently of the HDACs. Thus, RB family
members repress transcription by recruiting RBP1 to the pocket. RBP1,
in turn, serves as a bridging molecule to recruit HDACs and, in
addition, provides a second HDAC-independent repression function.
 |
INTRODUCTION |
The retinoblastoma (RB) tumor
suppressor protein pRB plays a critical role in the control of cell
proliferation. In addition, loss of the Rb gene is known to
contribute to the establishment of a variety of cancers. pRB and the
related proteins p130 and p107 control cell cycle progression through
interactions with the E2F family of transcription factors (reviewed in
reference 11). Such interactions regulate
transcription by mechanisms requiring the "pocket" domain of RB
family members (1, 3, 5, 18, 32, 39, 40, 46). One role of
the pocket is to interact with and mask the transcriptional activation
domain of E2F; however, this mechanism does not explain the repression of E2F-dependent promoters in which E2F binding sites act as negative elements that, if deleted, result in relief from repression (7, 11, 20, 28). The pocket can interact simultaneously with both E2F
and certain cellular and viral proteins that bind by utilizing a
conserved Leu-X-Cys-X-Glu (LXCXE) sequence (10, 14, 25, 38,
41). Many of these cellular LXCXE-containing proteins have been
shown to be transcriptional repressors, including RBP1 (24),
HBP1 (37), RIZ (4), RBP2 (unpublished data), and
histone deacetylase 1 (HDAC1) and HDAC2 (19, 42, 43). Recently, it has been proposed that the pockets of the pRB-E2F, p130-E2F, and p107-E2F complexes actively repress E2F-dependent transcription by two mechanisms, one involving the recruitment of HDAC1
(and possibly HDAC2) (2, 16, 26, 27) and the other
independent of HDACs (26, 30). HDACs are multiprotein complexes in which the human homologues of the yeast RPD3 protein, HDAC1, HDAC2, and HDAC3, constitute catalytic subunits (8, 13, 35,
42, 43). It is widely believed that histone deacetylation condenses chromatin structure, thereby shutting down transcription (reviewed in references 17, 19, 31, and
34). The recruitment of HDAC1 and HDAC2 to the
pocket may therefore account for active repression by RB family members
through deacetylation at the promoter level, and in fact, enzymatically
active forms of HDACs have been detected both in vitro and in vivo in
association with both the pocket and E2F (2, 26, 27).
Magnaghi-Jaulin et al. (27) and Ferreira et al.
(16) have shown that a region within HDAC1 containing an
IXCXE motif is important for interactions with RB family members
because its deletion resulted in a reduction in binding. Thus, it was
proposed that a direct physical interaction between the degenerate
IXCXE motif of HDAC1 and the pocket of RB family members occurs in
a manner analogous to interactions with LXCXE-containing viral
transforming proteins. One problem with this interpretation concerns
the fact that in addition to the IXCXE motif, the deletion mutants used
in these studies eliminated additional HDAC1-coding sequences. Second,
the in vitro binding assays used by these groups utilized HDAC1
translated in vitro with reticulocyte lysates. Thus, it is possible
that other factors might function in the interaction, perhaps even
serving as linkers for HDAC1. We present evidence herein that a known
RB pocket-binding protein, RBP1, links all three HDACs to RB proteins
and, in addition, provides a second HDAC-independent repression function.
 |
MATERIALS AND METHODS |
Cell culture and transfection.
Human lung carcinoma H1299
cells were grown in Dulbecco's modified Eagle medium containing 10%
fetal calf serum. 293 cells, 293T cells (a variant of 293 cells that
expresses simian virus 40 [SV40] large T antigen), and Chinese
hamster ovary (CHO) cells (ATCC CCL-61) were grown in
-minimal
essential medium supplemented with 10% fetal calf serum. Transfections
for binding studies were carried out with Lipofectamine reagents (NEN
Life Science), and transfections for chloramphenicol acetyltransferase
(CAT) assays were done by the calcium phosphate precipitation method
with the pGEM plasmid as the carrier DNA, as described previously
(24).
Antibodies.
A rabbit polyclonal antibody raised against
HDAC2 was described previously (23). Antibodies raised by E. Seto were prepared against peptides corresponding to the unique carboxy
termini of HDAC1 (EEKPEAKGVKEEVKLA) and HDAC3
(NEFYDGDHDNDKESDVEI), which had been coupled to keyhole
limpet hemocyanin and injected separately into New Zealand White
rabbits. The resulting antibodies were immunoaffinity purified on
peptide columns. LY11 and LY32 monoclonal antibodies raised by J. A. DeCaprio and W. G. Kaelin specifically against RBP1 were
described previously (24). Anti-pRB antibody G3-245 was
purchased from Pharmingen. Antibodies against p130 (C-20), p107 (C-18),
and the Gal4 DNA-binding domain (Gal4DBD) (RK5C1) were purchased from
Santa Cruz. Antihemagglutinin (anti-HA) antibody HA.11 was purchased
from Babco, and anti-Flag antibody M2 was from Sigma.
Plasmids.
A mammalian expression plasmid expressing the
small pocket of pRB as a fusion product with Gal4DBD, termed
Gal4-pRB(pocket), was provided by Tony Kouzarides (2).
Flag-HDAC1, -HDAC2, and -HDAC3 and Gal4-HDAC1, -HDAC2, and -HDAC3
constructs have been described elsewhere (42, 43). Gal4-VP16
was provided by Arnie Berk (44). Constructs expressing
Gal4-RBP1, RBP1-HA, Gal4-RBP1dl-LXCXE, and RBP1dl-LXCXE-HA mutants
which lack the LXCXE pocket-binding motif were described previously
(24). The G5TKCAT reporter construct has been described
elsewhere (36, 45). The G5MLPCAT reporter was provided by
Doug Dean (26). The E2F1-luc reporter construct has been
described elsewhere (24). Mutants of Gal4DBD-RBP1 were generated as follows. Gal4-dlR1 mutants were generated with two specific primers close to the 3' end of the region corresponding to R1
and the end of the RBP1-coding sequence. PCR was done to generate
fragments with unique restriction sites (Bsp1107I and HindIII) which were subcloned into digested RBP1
constructs, in which all the RBP1-coding sequences corresponding to
between the beginning of R1 and the end of the protein had been removed
with the same restriction enzymes. All carboxy-terminal-deletion
mutants of Gal4-dlR1 were generated from fragments produced by
restriction enzyme digestion of the Gal4-dlR1 plasmid DNA, and then
these were subcloned into a modified pcDNA3 (Invitrogen) construct
containing stop codons inserted 3' of the multicloning cassette.
Gal4-R2 truncation mutants were constructed by subcloning the
restriction enzyme-digested fragments of the Gal4-RBP1-coding region
that correspond to residues 1311 to 1404, 1314 to 1404, or 1263 to 1404 into pSG424. Mammalian expression plasmids encoding the pocket of pRB
and the inactive pRB pocket mutant mRB(C706F) were described previously
(22).
CAT,
-galactosidase, and luciferase assays.
Transcriptional analyses involving CAT,
-galactosidase, and
luciferase assays were performed as described previously (24, 36).
Binding assays.
One microgram each of cDNAs encoding
Gal4-pRB(pocket), RBP1, or RBP1 mutants was introduced with
Lipofectamine (NEN Life Science) along with 1 µg each of those
encoding Flag-tagged HDAC1, HDAC2, or HDAC3 into H1299 or 293T cells.
In some experiments, 1 µg each of cDNAs encoding HA-tagged RBP1
or RBP1 mutants was introduced with Lipofectamine along with 1 µg each of those encoding Gal4DBD-fused HDAC1, HDAC2, or HDAC3 into
H1299 or 293T cells. Cells were harvested 40 h posttransfection
and lysed with low-stringency buffer (24). Cell extracts
were diluted to 150 mM KCl in a 1-ml volume and precleared with protein
G-Sepharose (Pharmacia) for 2 h. Precleared extracts were
incubated with 1 µg of Gal4DBD antibody RK5C1 (Santa Cruz) and 30 µl of a 50% slurry of protein G-Sepharose for at least 12 h.
Immunoprecipitated Gal4-tagged protein complexes were washed six times
with lysis buffer and eluted by boiling in 2× sample buffer. Eluted
proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) with a 10% polyacrylamide gel, and proteins
were then transferred to polyvinylidene difluoride membranes
(Millipore) and were probed with either anti-HA (HA.11 [Babco]) or
anti-Flag (M2; Sigma) monoclonal antibody and then with horseradish
peroxidase-conjugated goat anti-mouse (
light chain-specific)
secondary antibody (PharMingen). Binding was detected by Enhanced
Luminol Reagent (NEN Life Science).
 |
RESULTS |
Endogenous interactions between RB family members and HDACs.
Coimmunoprecipitation experiments were conducted to determine the
ability of pRB to interact with various HDAC enzymes in vivo. Rabbit
polyclonal antibodies that specifically recognize HDAC2 (23)
or HDAC1 and HDAC3 (see Materials and Methods) were used under
low-stringency conditions to immunoprecipitate endogenous HDAC species
from extracts of H1299 cells. In each case, significant amounts of
corresponding HDAC proteins were immunoprecipitated (data not shown).
The presence of pRB in these complexes was determined by Western blot
analysis with the G3-245 monoclonal antibody, which recognizes both
hyperphosphorylated and hypophosphorylated forms of pRB. Figure
1A shows that the
hypophosphorylated form of pRB coprecipitated with HDAC1,
as reported by others (26). Interestingly, significant
amounts of hypophosphorylated pRB were also detected in association
with HDAC2 and HDAC3. These interactions are specific, as pRB was not
detected in immunoprecipitates prepared from the same cell extracts
with antibody to CREB-binding protein, a histone acetyltransferase
(data not shown). These results suggested that the active form of pRB
is able to recruit all three forms of the HDAC.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Endogenous interactions of pRB (A) and p107 (B) with
HDACs. (A) Immunoprecipitations were done in lysates from either H1299
or 293T cells. Plates (100 mm) of both cell types were lysed in
low-stringency buffer. Cell extracts were incubated with 1 µg of the
indicated antisera and 30 µl of a 50% slurry of protein G-Sepharose
for at least 12 h. Immunoprecipitated complexes were washed six
times with the 150 mM low-stringency buffer and eluted by boiling with
2× sample buffer. Eluted proteins were subjected to SDS-PAGE with a
6% polyacrylamide gel. The presence of pRB was detected with
monoclonal antibody (G3-245) against pRB (PharMingen). (B) Binding
studies similar to those described for panel A were done, but
coimmunoprecipitation of p107 was detected with a rabbit polyclonal
antibody (C-18) against p107 ( -107) (Santa Cruz).
|
|
Previous studies showed that HDAC1 also interacts with the pRB-related
family members p107 and p130 (
16,
21,
33). Thus,
immunoprecipitates from H1299 cells containing various HDACs were
immunoblotted with C-18 polyclonal antibody, which recognizes
up to
three different phosphorylated forms of p107 in various
cell lines.
Figure
1B shows that p107, its underphosphorylated
forms in particular,
also coprecipitated with all the endogenous
HDAC species, especially
HDAC1. We attempted a similar experiment
with p130, but as H1299 cells
die upon serum starvation and p130
is expressed largely at growth
arrest, we were unable to detect
sufficient quantities. Significant
amounts of p130 were present
in asynchronized H1299 cells, but these
p130 species were mostly
hyperphosphorylated and did not appear to
associate with HDACs
at significant levels (data not
shown).
Adenovirus E1A protein and SV40 large T antigen associate
with the pRB pocket via LXCXE-binding motifs (
12) and
have been
found to disrupt interactions between pRB and HDAC1 (
2,
26,
27). We therefore conducted a parallel series of binding
studies
in 293T cells, which express high levels of both adenovirus
type
5 (Ad5) E1A proteins and SV40 large T antigen. Figure
1A shows
that no interactions were apparent between pRB and any of the
HDAC
enzymes, including HDAC3. Figure
1B shows that a similar
effect was
apparent with p107. Thus, in both cases, binding of
all three HDAC
enzymes seemed to require the pocket region targeted
by DNA tumor virus
proteins.
The small pocket interacts with different HDACs.
It has been
proposed that HDAC1 utilizes a degenerate IXCXE motif to interact with
the small pocket (residues 379 to 792) of pRB (16, 27). To
directly determine if this region is involved in the binding of all of
the HDACs, studies were carried out with extracts from H1299 cells
cotransfected with plasmid DNAs expressing Gal4-pRB(pocket) and
Flag-tagged versions of HDAC1, HDAC2, or HDAC3. Following
immunoprecipitation with an antibody against the Gal4DBD, precipitates
were resolved by SDS-PAGE, and after transfer, the presence of HDAC1 to
HDAC3 was analyzed by Western blotting with anti-Flag antibody. Figure
2A shows that all three HDACs, which were
detected at similar levels in whole-cell extracts, associated with the
small pocket of pRB in vivo. Anti-Flag antibody recognized three
Flag-HDAC1 species, but only the slowest-migrating form was evident in
Gal4-pRB(pocket) precipitates, suggesting that the faster-migrating
species may be degradation products. Flag-HDAC3 was detected as two
closely migrating species that were both associated with the
Gal4-pRB(pocket). These interactions were highly specific; a cDNA
expressing the Gal4DBD linked to VP16, a known transcriptional
activator, did not associate with any of the HDACs (Fig. 2A) even
though Gal4-pRB(pocket) and Gal4-VP16 were expressed at comparable
levels (data not shown). We believe that these results, as well as
those described above for antibody against CREB-binding protein,
demonstrate clearly the specificity of interactions involving HDACs and
rule out the possibility that the interactions we observed were
nonspecific.


View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
In vivo interaction of the small pocket of pRB with
HDACs. (A) cDNAs encoding the Gal4DBD fused with the pocket of pRB were
overexpressed with those encoding Flag-tagged HDAC1, HDAC2, or HDAC3 in
H1299 cells. RK5C1 (anti-Gal4DBD) antibody (Santa Cruz) was used to
immunoprecipitate Gal4-tagged overexpressed proteins, and the
coimmunoprecipitation of HDACs was detected by Western blotting with
anti-Flag M2 monoclonal antibody (Sigma). WC, whole-cell extracts; IP,
anti-Gal4-immunoprecipitated proteins. Binding studies similar to those
described for panel A were performed with 293T (B) and 293 (C) cells.
(D) A modified binding experiment similar to that described for panel A
was done with H1299 cells by incubating cell extracts with increasing
amounts (0 to 20 µg) of E1A protein (the first exon of the gene
containing the LXCXE motif) fused to GST (GST-E1A) and synthesized in
vitro in bacteria (6). The positions of migration of
Flag-tagged HDAC1 (open arrow), HDAC2 (closed arrow), and HDAC3
(arrowhead) are indicated.
|
|
Figure
2B shows that in a similar experiment with 293T cells, none of
the HDAC proteins were present in immunoprecipitates
containing
Gal4-pRB(pocket). Identical results were also obtained
with 293 cells,
which express only Ad5 E1A proteins (Fig.
2C).
Figure
2D shows that
addition prior to immunoprecipitation of
increasing amounts of in
vitro-synthesized E1A protein fused to
glutathione
S-transferase (GST-E1A) (
6) to extracts from
H1299
cells expressing Gal4-pRB(pocket) and Flag-HDAC1 caused a
decrease
in the binding of HDAC1 to the small pocket of pRB. Figure
2D
also demonstrates that pRB coimmunoprecipitated with E1A protein
but
not with GST. Similar results were also obtained with Flag-HDAC2
and
Flag-HDAC3 (data not shown). Thus, the small pocket of pRB
is important
for interactions not only with HDAC1 but also with
HDAC2 and HDAC3.
Disruption of such binding by the E1A protein
or T antigen also implied
that the associations of HDACs may be
mediated by LXCXE-like
interactions. Although HDAC1 and HDAC2
contain IXCXE motifs, the
mechanism of binding of HDAC3 was uncertain,
as HDAC3 lacks such
sequences. Of further interest, no interaction
between the pocket of
pRB and HDAC1 (
2) or HDAC2 (
32a) was
observed in
studies involving the yeast two-hybrid method. As
all three human HDACs
are highly homologous, it is possible that
the interactions of all
three with the pocket may be indirect
and may involve an additional
LXCXE-containing protein as a
linker.
One possible candidate for a linker is RBP1, a known nuclear
pRB-binding phosphoprotein that interacts with the pocket via
an LXCXE
motif (
9,
15,
22). In previous studies, it was
shown that
RBP1 associates with both pRB-E2F and p130-E2F complexes
following
serum starvation and, if overexpressed, induces both
growth arrest and
repression of E2F-dependent transcription (
24).
In addition,
in studies involving RBP1 fused to the Gal4DBD, RBP1
was shown to be an
active repressor containing an isolable repression
domain
(
24), termed
R1.
RBP1 interacts with HDACs in vivo.
The ability of RBP1 to
associate with HDACs in vivo was tested. A binding experiment similar
to that described above for Gal4-pRB(pocket) was performed with RBP1
fused to the Gal4DBD. Figure
3A
shows that when expressed in H1299 cells, Gal4-RBP1, but not Gal4-VP16, interacted with all three HDACs. Again, only the slowest-migrating Flag-HDAC1 species was evident, and Flag-HDAC3 was present as a doublet
in Gal4-RBP1 precipitates.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
In vivo interaction of RBP1 with HDACs. Binding
studies similar to those described for Fig. 2A and B were performed
with H1299 cells (A) and 293T cells (B) by using Gal4-RBP1 instead of
Gal4-pRB. (C) Binding studies similar to those described for panel B
were performed in 293T cells transfected with the RBP1-HA construct
(24) and the Gal4-HDAC1, Gal4-HDAC2, and Gal4-HDAC3
constructs (42, 43). Molecular mass was determined with
Rainbow Color Marker RPN-756 (Amersham Life Science). (D) A binding
study similar to that described for panels B and C was done with the
Gal4-RBP1dl-LXCXE and RBP1dl-LXCXE-HA mutants, which lack the LXCXE
pocket-binding motif (24). The positions of migration of
Flag-tagged HDAC1 (open arrows), HDAC2 (closed arrow), and HDAC3
(arrowhead) are indicated. (E) Coimmunoprecipitation studies similar to
those for Fig. 1 were done with both H1299 and 293T cells. In addition
to the antisera described, antibodies against pRB (G3-245), p130 (C-20
polyclonal) (Santa Cruz), p107 (C-18), and the HA epitope (HA.11) were
used. Coimmunoprecipitation with RBP1 was detected with a monoclonal
antibody raised specifically against RBP1 (LY32).
|
|
Figure
3B shows that in 293T cells expressing E1A products and SV40
large T antigen, both HDAC1 and HDAC3 associated with
Gal4-RBP1,
indicating that these interactions were unaffected
by high levels of
these viral pocket-binding proteins. The binding
of HDAC2 was not
highly evident under these conditions. Whereas
Flag-HDAC1 and
Flag-HDAC3 expression relied on the cytomegalovirus
promoter
(
32a) that yielded high levels of these products, the
expression of Flag-HDAC2 was achieved in these experiments with
a
hybrid SV40-human T-cell leukemia virus type 1 promoter that
produced
smaller amounts of product in 293T and 293 cells (Fig.
2C). To
reexamine RBP1-HDAC binding under conditions in which
all three HDACs
were expressed at high levels, constructs in which
all three HDACs were
expressed in 293T cells along with HA-tagged
RBP1 as Gal4DBD-HDAC
fusion products under the control of the
SV40 early promoter were
prepared. Figure
3C shows that all the
HDACs were expressed at
comparable levels, as determined by the
immunoblotting of whole-cell
extracts with anti-Gal4DBD antibody.
Similarly, all cells expressed
comparable amounts of RBP1, as
detected with anti-HA antibody. Figure
3C also shows that interactions
between all three HDACs and HA-RBP1
were evident following the
immunoblotting of individual HDAC
immunoprecipitates with anti-HA
antibody. No such binding was observed
with Gal4 alone or with
Gal4-VP16. Figure
3E shows that interactions
between RBP1 and
endogenous HDAC enzymes could also be detected in
H1299 cells.
With immunoprecipitates prepared with the same polyclonal
antibodies
against individual HDACs as employed for Fig.
1, RBP1 was
found
to be in association with all three HDACs, as detected by
immunoblotting
with LY32 monoclonal antibody, raised against human RBP1
and found
previously to interact specifically with this polypeptide
(
8a).
Interactions with HDAC1 clearly occurred at much
higher levels
than those with HDAC2 and HDAC3, implying that RBP1-HDAC1
complexes
are the predominant species in H1299 cells. This observation
may
suggest that RBP1 could be a component of the HDAC1 core complex.
If this is the case, much of the endogenous RBP1-HDAC1 complex
could be
targeted to sites other than RB family members, as the
levels of RBP1
detected in association with these proteins were
much lower than those
observed with HDAC1. Figure
3E also shows
that RBP1 associates with all
members of the RB family, and examination
of pertinent lanes in Fig.
1
indicated that this association occurred
preferentially with
hypophosphorylated forms of pRB (Fig.
1A)
and p107 (Fig.
1B). In
addition, Fig.
3E shows that such interactions
of RBP1 with pRB, p107,
and p130 were disrupted in 293T cells,
as expected. Taken together,
these results suggest that interactions
between RBP1 and RB family
members are truly pocket dependent,
as they were disrupted by T antigen
and E1A pocket-binding proteins.
On the other hand, interactions
between RBP1 and HDACs are not
at all sensitive to disruption by these
viral pocket-binding proteins,
suggesting that HDACs cannot be
recruited to RBP1 via endogenous
RB family members present in 293T
cells. Instead, RBP1 could mediate
the association between RB family
members and all three HDAC
enzymes.
It is unlikely that the interactions of HDACs with RBP1 occur
indirectly through the recruitment of RB family members by RBP1.
In
293T and 293 cells, we failed to observe interactions either
between
the pocket of pRB and these enzymes (Fig.
2B and C) or
between RBP1 and
RB family members (Fig.
1 and
3E). In addition,
we studied interactions
between the HDACs and an RBP1 mutant,
RBP1dl-LXCXE, that fails to
interact with pRB because of the removal
of the conserved LXCXE
pocket-binding motif by an internal deletion
(
9,
24). Figure
3D shows that in 293T cells, both Gal4-RBP1dl-LXCXE
and RBP1dl-LXCXE-HA
mutants interacted with Flag-tagged or Gal4DBD-tagged
HDACs. Similar
results were also obtained with human H1299 cells
(data not shown).
Thus, HDACs appear to interact with RBP1 in
a region apart from the
pocket-binding motif, further supporting
a role for RBP1 in bridging
interactions between HDACs and pRB-E2F
complexes.
RBP1 contains two independent transcriptional repression
domains.
Previous studies showed the existence of both
pRB-E2F-RBP1 and p130-E2F-RBP1 complexes in growth-arrested cells that
correlated with the ability of RB family members to actively repress
E2F-dependent transcription (24). These studies also used
Gal4-RBP1 fusion products to map a repression domain, R1, between
residues 388 and 599 of RBP1, comprising an ARID sequence and a region
predicted to have an
-helical structure. Figure 4A shows that
Gal4-RBP1 is able to repress the expression of CAT under the control of the Gal4 minimal herpesvirus thymidine kinase promoter. Similar repression was also seen with Gal4-R1 that contains only the R1 repression domain of RBP1. Curiously, when R1 was deleted
(Gal4-RBP1dl-R1), this mutant RBP1 product still repressed CAT
expression at high levels (Fig.
4A),
suggesting that a second repression domain may exist towards the
carboxy terminus of RBP1. We therefore generated a series of in-frame
carboxy-terminal-deletion mutants that also lacked R1 (Fig. 4B) and
found that all, including Gal4-dl-R1-93C, which lacked only 93 residues
at the carboxy terminus, failed to repress CAT expression (Fig. 4A).
All mutants used in the experiments illustrated in Fig. 4 were shown to
be expressed at similarly high levels (data not shown). As these data
suggested that the second repression domain likely lies at the most
carboxy-terminal portion, three additional constructs that contained
only various amounts of the carboxy terminus of RBP1 linked to the
Gal4DBD were generated. Figure 4A shows that all three constructs,
Gal4-R2(1311-C), Gal4-R2(1314-C), and Gal4-R2(1263-C), repressed CAT
expression. Thus, a second RBP1 repression domain, R2, exists between
residues 1314 and 1404. Furthermore, repression by neither R1 nor R2
relies on the LXCXE pocket-binding motif when RBP1 is tethered to DNA by a heterologous DNA-binding domain, like the Gal4DBD.


View larger version (72K):
[in this window]
[in a new window]
|
FIG. 4.
Mapping of transcriptional repression domains in RBP1
and effect of TSA on RBP1 repression activity. (A) Repression by RBP1
mutants. CAT assays were performed with CHO cells, as described
previously (24), with G5TKCAT as the reporter. (B)
Illustration of the Gal4DBD-RBP1 mutants. The name of each mutant is
provided, as well as the amino acid residues affected by deletions. A
summary of repression results (Rep.) obtained in experiments described
for panel A is shown at the left. NLS, nuclear localization signal. (C)
Effect of TSA on repression. Repression assays were carried out as for
panel A, except that some cells were incubated with 330 nM TSA for
24 h prior to harvesting and the G5MLPCAT reporter was assayed
instead of the G5TKCAT reporter. (D) An experiment similar to that
described for panel C was performed with a reporter construct
consisting of the E2F-1 promoter linked to a cDNA encoding luciferase,
as described previously (24), and either RBP1, RBP1dl-LXCXE,
the pocket of pRB, or an inactive pRB pocket mutant, mRB(C706F) mutant
(22). All data are the averages (± standard errors) of at
least six individual experiments.
|
|
Transcriptional repression by RBP1 is both dependent and
independent of HDAC activity.
Previous studies by Luo et al.
(26) suggested that the ability of the pocket to actively
repress transcription relies on both HDAC-dependent and -independent
mechanisms. These authors also showed that only a subset of promoters
repressed by the pocket of pRB was sensitive to the specific HDAC
inhibitor trichostatin A (TSA). Among these, the only Gal4-dependent
promoter/reporter construct found to be repressed by the pocket and to
be sensitive to TSA is G5MLPCAT, which contains the adenovirus major
late promoter. Figure 4C shows that both Gal4-RBP1 and Gal4-pRB(pocket)
repressed the G5MLPCAT reporter, as did both Gal4-R1 and Gal4-R2, which contain only R1 and R2, respectively. Figure 4C also shows that following the treatment of transfected cells with 330 nM TSA for 24 h prior to harvesting, repression by both Gal4-pRB(pocket) and
Gal4-RBP1 was partially relieved; however, whereas drug treatment completely abolished repression by Gal4-R2, it had no effect on that by
Gal4-R1. Thus, it appears that repression by R2 depends on HDACs,
whereas that by R1 does not. We also noted that whereas Gal4-HDAC1
repression activity is completely relieved by TSA (Fig. 4C), repression
by Gal4-Ad5-E1B-55K, an adenoviral repressor known to block
p53-dependent transactivation (36, 45), at this promoter is
not affected by TSA (data not shown), suggesting that the adenovirus major late promoter can be subject to both HDAC-dependent and -independent repression. These results therefore strengthen the possibility that RBP1 plays an important role in repression by pRB, as
TSA only partially relieves repression by the pRB pocket. Interestingly, TSA had little effect on repression by Gal4-RBP1 or
Gal4-R2 with either the G5TKCAT or G5SV40CAT promoter (data not shown),
as determined previously with Gal4-pRB(pocket) by Luo et al.
(26). Studies were extended from the synthetic G5MLPCAT construct to the E2F-dependent promoter regulating E2F-1 expression (E2F1-luc). Figure 4D shows that both RBP1 and the pocket of pRB repressed the expression of luciferase from the E2F1-luc reporter, whereas RBP1 lacking the LXCXE pocket-binding motif or a pRB point mutant [mRB(C706F)] did not. Members of our group had demonstrated previously that mutation of the E2F binding site in this reporter ablated repression by RBP1 (24). Addition of TSA partially
relieved repression by both RBP1 and the pRB pocket. These results
indicated that both the RBP1 HDAC-dependent and -independent repression activities can repress this E2F-dependent promoter via interactions with RB family members, and thus interactions with RBP1 could provide
both types of repression activities attributed to the pocket of RB
family members (26).
Only one repression domain of RBP1 interacts with HDACs.
We
tested the ability of individual R1 and R2 transcriptional repression
domains to interact with HDACs. Figure 5
shows results of coimmunoprecipitation experiments using 293T cells
expression Gal4-RBP1 constructs and Flag-HDAC3, in which RBP1 was
immunoprecipitated with anti-Gal4DBD antibodies and HDAC3 binding was
detected by immunoblotting with anti-Flag antibody. No HDAC3 binding
was observed with either all of R1 or just the ARID portion of R1, but
such binding was clearly evident with both R2 constructs and with RBP1 lacking R1. Binding was eliminated or greatly reduced with RBP1 lacking
R2. Similar results were also obtained with Flag-HDAC1 and Flag-HDAC2
(data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
Mapping of specific binding of HDAC3 to RBP1. Binding
studies similar to those described for Fig. 3B were done with 293T
cells by using either Gal4-R1, Gal4-R2(1314-C), Gal4-R2(1263-C), Gal4
alone, Gal4-RBP1 (wild type [WT]), Gal4-ARID, Gal4-dlR1, or
Gal4-dl-93C(dl-R2).
|
|
 |
DISCUSSION |
The present study reports for the first time that the pocket of
pRB, and possibly other RB family members, interacts with all three
cloned human HDACs. Furthermore, the RB-binding protein RBP1 also binds
these enzymes, but unlike pRB, the pocket-binding E1A protein and large
T antigen do not affect interactions between RBP1 and any of the HDACs.
It is currently believed that HDAC1 or HDAC2 interacts directly with
the pocket via degenerate IXCXE motifs, but this model does not account
for the interactions of HDAC3, which lacks such sequences. Our data
indicated that the binding of HDAC3 to RB family members also requires
the pocket, suggesting that, in this case at least, such interactions
may be indirect and rely on a pocket-binding protein, such as RBP1. The
previous observation that RBP1 is present in pRB-E2F and p130-E2F complexes following serum starvation and the effects of its
overexpression on inducing growth arrest and the repression of
E2F-dependent transcription (24) suggest that RBP1 may be
functionally important in the repression of E2F-dependent transcription
by linking HDACs to the pockets of RB family proteins. Figure
6 shows a model in which the repression
of E2F-dependent transcription by pRB and p130 at growth arrest or by
p107 in G1 results from the binding of RBP1 at the pocket,
thus introducing not only HDACs via interactions with the R2 domain but
also a second R1 repression domain that functions by another mechanism.
At present, it is not known if HDACs bind directly to the RBP1 or if
they interact indirectly via an additional R2-binding protein. Previous
work with anti-RBP1 LY11 antibodies indicated the presence of several
proteins that coprecipitate with RBP1, including pRB and p130
(24). The most prominent species was a protein of about 48 kDa. HDAC1 copurifies with RBAP48, which, along with RBAP46, plays a
role in targeting HDAC1 to histones (47). It is possible
that both RBP1 and either RBAP48 or RBAP46 could coexist in a single
HDAC complex. RBAP48 binds to the so-called extended pocket, including
a carboxy-terminal portion of pRB, and thus might play a role as a
linker for HDAC1; however, it lacks the LXCXE-binding motif and thus is
not targeted to the small pocket. In addition, no interactions between
the pRB pocket and HDAC1 (2) or HDAC2 (32a) have
been detected by the yeast two-hybrid system, even though yeast cells
contain high levels of MSI1, a protein that is highly homologous to
RBAP48 and RBAP46 (47). The present results strongly suggest
that RBP1 is responsible for bridging the pocket of RB family members
to HDAC complexes to repress a diversity of E2F-dependent promoters.
RBP1 therefore appears to represent a major component of the
growth-regulatory machinery controlled by RB family members.
 |
ACKNOWLEDGMENTS |
We thank Tony Kouzarides for Gal4-pRB(pocket) and for helpful
discussions; Xiang-Jiao Yang and Brian Kennedy for critical review of
the manuscript; Arnie Berk for Gal4-VP16, pSG424, and G5TKCAT; and Doug
Dean and Don Ayer for G5MLPCAT and G5SV40CAT. We also thank Dennis
Paquette for the construction of the Gal4-RBP1dl-R1 mutant.
This work was supported through grants from the National Cancer
Institute of Canada and the Medical Research Council of Canada.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departments of
Biochemistry and Oncology, McGill University, McIntyre Medical
Building, 3655 Drummond St., Montreal, Quebec, Canada H3G 1Y6. Phone:
(514) 398-7268. Fax: (514) 398-7384. E-mail:
branton{at}med.mcgill.ca.
 |
REFERENCES |
| 1.
|
Adnane, J.,
Z. Shao, and P. D. Robbins.
1995.
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter.
J. Biol. Chem.
270:8837-8843[Abstract/Free Full Text].
|
| 2.
|
Brehm, A.,
E. A. Miska,
D. J. McCance,
J. L. Reid,
A. J. Bannister, and T. Kouzarides.
1998.
Retinoblastoma protein recruits histone deacetylase to repress transcription.
Nature
391:597-601[Medline].
|
| 3.
|
Bremner, R.,
B. L. Cohen,
M. Sopta,
P. A. Hamel,
C. J. Ingles,
B. L. Gallie, and R. A. Phillips.
1995.
Direct transcriptional repression by pRB and its reversal by specific cyclins.
Mol. Cell. Biol.
15:3256-3265[Abstract].
|
| 4.
|
Buyse, I. M.,
G. Shao, and S. Huang.
1995.
The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.
Proc. Natl. Acad. Sci. USA
92:4467-4471[Abstract/Free Full Text].
|
| 5.
|
Chow, K. N. B., and D. C. Dean.
1996.
Domains A and B in the Rb pocket interact to form a transcriptional repressor motif.
Mol. Cell. Biol.
16:4862-4868[Abstract].
|
| 6.
|
Corbeil, H. B., and P. E. Branton.
1994.
Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
J. Virol.
68:6697-6709[Abstract/Free Full Text].
|
| 7.
|
Dalton, S.
1992.
Cell cycle regulation of the human cdc2 gene.
EMBO J.
11:1797-1804[Medline].
|
| 8.
|
Dangond, F.,
D. A. Hafler,
J. K. Tong,
J. Randall,
R. Kojima,
N. Utku, and S. R. Gullans.
1998.
Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells.
Biochem. Biophys. Res. Commun.
242:648-652[Medline].
|
| 8a.
| DeCaprio, J., and W. Kaelin. Unpublished results.
|
| 9.
|
Defeo-Jones, D.,
P. S. Huang,
R. E. Jones,
K. M. Haskell,
G. A. Vuocolo,
M. G. Hanobik,
H. E. Huber, and A. Oliff.
1991.
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product.
Nature
352:251-254[Medline].
|
| 10.
|
Dunaief, J. L.,
B. E. Strober,
S. Guha,
P. A. Khavari,
K. Alin,
J. Luban,
M. Begemann,
G. R. Crabtree, and S. P. Goff.
1994.
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest.
Cell
79:119-130[Medline].
|
| 11.
|
Dyson, N.
1998.
The regulation of E2F by pRB-family proteins.
Genes Dev.
12:2245-2262[Free Full Text].
|
| 12.
|
Dyson, N.,
P. Guida,
C. McCall, and E. Harlow.
1992.
Adenovirus E1A makes two distinct contacts with the retinoblastoma protein.
J. Virol.
66:4606-4611[Abstract/Free Full Text].
|
| 13.
|
Emiliani, S.,
W. Fischle,
C. Van Lint,
Y. Al-Abed, and E. Verdin.
1998.
Characterization of a human RPD3 ortholog, HDAC3.
Proc. Natl. Acad. Sci. USA
95:2795-2800[Abstract/Free Full Text].
|
| 14.
|
Fattaey, A. R.,
E. Harlow, and K. Helin.
1993.
Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Mol. Cell. Biol.
13:7267-7277[Abstract/Free Full Text].
|
| 15.
|
Fattaey, A. R.,
K. Helin,
M. S. Dembski,
N. Dyson,
E. Harlow,
G. A. Vuocolo,
M. G. Hanobik,
K. M. Haskell,
A. Oliff,
D. Defeo-Jones, et al.
1993.
Characterization of the retinoblastoma binding proteins RBP1 and RBP2.
Oncogene
8:3149-3156[Medline].
|
| 16.
|
Ferreira, R.,
L. Magnaghi-Jaulin,
P. Robin,
A. Harel-Bellan, and D. Trouche.
1998.
The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Proc. Natl. Acad. Sci. USA
95:10493-10498[Abstract/Free Full Text].
|
| 17.
|
Grunstein, M.
1997.
Histone acetylation in chromatin structure and transcription.
Nature
389:349-352[Medline].
|
| 18.
|
Hamel, P. A.,
R. M. Gill,
R. A. Phillips, and B. L. Gallie.
1992.
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
Mol. Cell. Biol.
12:3431-3438[Abstract/Free Full Text].
|
| 19.
|
Hassig, C. A.,
J. K. Tong,
T. C. Fleischer,
T. Owa,
P. G. Grable,
D. E. Ayer, and S. L. Schreiber.
1998.
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
Proc. Natl. Acad. Sci. USA
95:3519-3524[Abstract/Free Full Text].
|
| 20.
|
Hsiao, K. M.,
S. L. McMahon, and P. J. Farnham.
1994.
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Genes Dev.
8:1526-1537[Abstract/Free Full Text].
|
| 21.
|
Iavarone, A., and J. Massagué.
1999.
E2F and histone deacetylase mediate transforming growth factor repression of cdc25A during keratinocyte cell cycle arrest.
Mol. Cell. Biol.
19:916-922[Abstract/Free Full Text].
|
| 22.
|
Kaelin, W. G., Jr.,
W. Krek,
W. R. Sellers,
J. A. DeCaprio,
F. Ajchenbaum,
C. S. Fuchs,
T. Chittenden,
Y. Li,
P. J. Farnham,
M. A. Blanar, et al.
1992.
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
Cell
70:351-364[Medline].
|
| 23.
|
Laherty, C. D.,
W. M. Yang,
J. M. Sun,
J. R. Davie,
E. Seto, and R. N. Eisenman.
1997.
Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
Cell
89:349-356[Medline].
|
| 24.
|
Lai, A.,
R. C. Marcellus,
H. B. Corbeil, and P. E. Branton.
1999.
RBP1 induces growth arrest by repression of E2F-dependent transcription.
Oncogene
18:2091-2100[Medline].
|
| 25.
|
Lee, J. O.,
A. A. Russo, and N. P. Pavletich.
1998.
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
Nature
391:859-865[Medline].
|
| 26.
|
Luo, R. X.,
A. A. Postigo, and D. C. Dean.
1998.
Rb interacts with histone deacetylase to repress transcription.
Cell
92:463-473[Medline].
|
| 27.
|
Magnaghi-Jaulin, L.,
R. Groisman,
I. Naguibneva,
P. Robin,
S. Lorain,
J. P. Le Villain,
F. Troalen,
D. Trouche, and A. Harel-Bellan.
1998.
Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
Nature
391:601-605[Medline].
|
| 28.
|
Ohtani, K.,
J. DeGregori, and J. R. Nevins.
1995.
Regulation of the cyclin E gene by transcription factor E2F1.
Proc. Natl. Acad. Sci. USA
92:12146-12150[Abstract/Free Full Text].
|
| 29.
|
Pazin, M. J., and J. T. Kadonaga.
1997.
What's up and down with histone deacetylation and transcription?
Cell
89:325-328[Medline].
|
| 30.
|
Ross, J. F.,
X. Liu, and B. D. Dynlacht.
1999.
Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein.
Mol. Cell
3:195-205[Medline].
|
| 31.
|
Roth, S. Y., and C. D. Allis.
1996.
Histone acetylation and chromatin assembly: a single escort, multiple dances?
Cell
87:5-8[Medline].
|
| 32.
|
Sellers, W. R.,
J. W. Rodgers, and W. G. Kaelin, Jr.
1995.
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Proc. Natl. Acad. Sci. USA
92:11544-11548[Abstract/Free Full Text].
|
| 32a.
| Seto, E. Unpublished data.
|
| 33.
|
Stiegler, P.,
A. De Luca,
L. Bagella, and A. Giordano.
1998.
The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Cancer Res.
58:5049-5052[Abstract/Free Full Text].
|
| 34.
|
Struhl, K.
1998.
Histone acetylation and transcriptional regulatory mechanisms.
Genes Dev.
12:599-606[Free Full Text].
|
| 35.
|
Taunton, J.,
C. A. Hassig, and S. L. Schreiber.
1996.
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p.
Science
272:408-411[Abstract].
|
| 36.
|
Teodoro, J. G., and P. E. Branton.
1997.
Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5.
J. Virol.
71:3620-3627[Abstract].
|
| 37.
|
Tevosian, S. G.,
H. H. Shih,
K. G. Mendelson,
K. A. Sheppard,
K. E. Paulson, and A. S. Yee.
1997.
HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.
Genes Dev.
11:383-396[Abstract/Free Full Text].
|
| 38.
|
Trouche, D.,
C. Le Chalony,
C. Muchardt,
M. Yaniv, and T. Kouzarides.
1997.
RB and hbrm cooperate to repress the activation functions of E2F1.
Proc. Natl. Acad. Sci. USA
94:11268-11273[Abstract/Free Full Text].
|
| 39.
|
Weintraub, S. J.,
K. N. Chow,
R. X. Luo,
S. H. Zhang,
S. He, and D. C. Dean.
1995.
Mechanism of active transcriptional repression by the retinoblastoma protein.
Nature
375:812-815[Medline].
|
| 40.
|
Weintraub, S. J.,
C. A. Prater, and D. C. Dean.
1992.
Retinoblastoma protein switches the E2F site from positive to negative element.
Nature
358:259-261[Medline].
|
| 41.
|
Welch, P. J., and J. Y. Wang.
1993.
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
Cell
75:779-790[Medline].
|
| 42.
|
Yang, W. M.,
C. Inouye,
Y. Zeng,
D. Bearss, and E. Seto.
1996.
Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.
Proc. Natl. Acad. Sci. USA
93:12845-12850[Abstract/Free Full Text].
|
| 43.
|
Yang, W. M.,
Y. L. Yao,
J. M. Sun,
J. R. Davie, and E. Seto.
1997.
Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.
J. Biol. Chem.
272:28001-28007[Abstract/Free Full Text].
|
| 44.
|
Yew, P. R., and A. J. Berk.
1992.
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.
Nature
357:82-85[Medline].
|
| 45.
|
Yew, P. R.,
X. Liu, and A. J. Berk.
1994.
Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.
Genes Dev.
8:190-202[Abstract/Free Full Text].
|
| 46.
|
Zacksenhaus, E.,
Z. Jiang,
R. A. Phillips, and B. L. Gallie.
1996.
Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
EMBO J.
15:5917-5927[Medline].
|
| 47.
|
Zhang, Y.,
Z. W. Sun,
R. Iratni,
H. Erdjument-Bromage,
P. Tempst,
M. Hampsey, and D. Reinberg.
1998.
SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex.
Mol. Cell
1:1021-1031[Medline].
|
Molecular and Cellular Biology, October 1999, p. 6632-6641, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ishimaru, N., Arakaki, R., Yoshida, S., Yamada, A., Noji, S., Hayashi, Y.
(2008). Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. JEM
205: 2915-2927
[Abstract]
[Full Text]
-
Wu, M.-Y., Eldin, K. W., Beaudet, A. L.
(2008). Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes. JNCI J Natl Cancer Inst
100: 1247-1259
[Abstract]
[Full Text]
-
Seifried, L. A., Talluri, S., Cecchini, M., Julian, L. M., Mymryk, J. S., Dick, F. A.
(2008). pRB-E2F1 Complexes Are Resistant to Adenovirus E1A-Mediated Disruption. J. Virol.
82: 4511-4520
[Abstract]
[Full Text]
-
Hurst, D. R., Xie, Y., Vaidya, K. S., Mehta, A., Moore, B. P., Accavitti-Loper, M. A., Samant, R. S., Saxena, R., Silveira, A. C., Welch, D. R.
(2008). Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells. J. Biol. Chem.
283: 7438-7444
[Abstract]
[Full Text]
-
Kong, L., Yu, X.-P., Bai, X.-H., Zhang, W.-F., Zhang, Y., Zhao, W.-M., Jia, J.-H., Tang, W., Zhou, Y.-B., Liu, C.-j.
(2007). RbAp48 Is a Critical Mediator Controlling the Transforming Activity of Human Papillomavirus Type 16 in Cervical Cancer. J. Biol. Chem.
282: 26381-26391
[Abstract]
[Full Text]
-
Escaffit, F., Vaute, O., Chevillard-Briet, M., Segui, B., Takami, Y., Nakayama, T., Trouche, D.
(2007). Cleavage and Cytoplasmic Relocalization of Histone Deacetylase 3 Are Important for Apoptosis Progression. Mol. Cell. Biol.
27: 554-567
[Abstract]
[Full Text]
-
Wu, M.-Y., Tsai, T.-F., Beaudet, A. L.
(2006). Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain.. Genes Dev.
20: 2859-2870
[Abstract]
[Full Text]
-
Monroe, D. G., Secreto, F. J., Hawse, J. R., Subramaniam, M., Khosla, S., Spelsberg, T. C.
(2006). Estrogen Receptor Isoform-specific Regulation of the Retinoblastoma-binding Protein 1 (RBBP1) Gene: ROLES OF AF1 AND ENHANCER ELEMENTS. J. Biol. Chem.
281: 28596-28604
[Abstract]
[Full Text]
-
Harbour, J. W.
(2006). Eye Cancer: Unique Insights into Oncogenesis The Cogan Lecture. IOVS
47: 1737-1745
[Full Text]
-
Ishimaru, N., Arakaki, R., Omotehara, F., Yamada, K., Mishima, K., Saito, I., Hayashi, Y.
(2006). Novel Role for RbAp48 in Tissue-Specific, Estrogen Deficiency-Dependent Apoptosis in the Exocrine Glands. Mol. Cell. Biol.
26: 2924-2935
[Abstract]
[Full Text]
-
Binda, O., Roy, J.-S., Branton, P. E.
(2006). RBP1 Family Proteins Exhibit SUMOylation-Dependent Transcriptional Repression and Induce Cell Growth Inhibition Reminiscent of Senescence.. Mol. Cell. Biol.
26: 1917-1931
[Abstract]
[Full Text]
-
Singh, M., Krajewski, M., Mikolajka, A., Holak, T. A.
(2005). Molecular Determinants for the Complex Formation between the Retinoblastoma Protein and LXCXE Sequences. J. Biol. Chem.
280: 37868-37876
[Abstract]
[Full Text]
-
Meloni, A. R., Lai, C.-H., Yao, T.-P., Nevins, J. R.
(2005). A Mechanism of COOH-Terminal Binding Protein-Mediated Repression. Mol Cancer Res
3: 575-583
[Abstract]
[Full Text]
-
Gray, S. G., Iglesias, A. H., Lizcano, F., Villanueva, R., Camelo, S., Jingu, H., Teh, B. T., Koibuchi, N., Chin, W. W., Kokkotou, E., Dangond, F.
(2005). Functional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein. J. Biol. Chem.
280: 28507-28518
[Abstract]
[Full Text]
-
Wright, E., Bain, M., Teague, L., Murphy, J., Sinclair, J.
(2005). Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells. J. Gen. Virol.
86: 535-544
[Abstract]
[Full Text]
-
Patsialou, A., Wilsker, D., Moran, E.
(2005). DNA-binding properties of ARID family proteins. Nucleic Acids Res
33: 66-80
[Abstract]
[Full Text]
-
Ding, Z., Gillespie, L. L., Mercer, F. C., Paterno, G. D.
(2004). The SANT Domain of Human MI-ER1 Interacts with Sp1 to Interfere with GC Box Recognition and Repress Transcription from Its Own Promoter. J. Biol. Chem.
279: 28009-28016
[Abstract]
[Full Text]
-
Pennaneach, V., Barbier, V., Regazzoni, K., Fotedar, R., Fotedar, A.
(2004). Rb Inhibits E2F-1-induced Cell Death in a LXCXE-dependent Manner by Active Repression. J. Biol. Chem.
279: 23376-23383
[Abstract]
[Full Text]
-
Meehan, W. J., Samant, R. S., Hopper, J. E., Carrozza, M. J., Shevde, L. A., Workman, J. L., Eckert, K. A., Verderame, M. F., Welch, D. R.
(2004). Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription. J. Biol. Chem.
279: 1562-1569
[Abstract]
[Full Text]
-
Siddiqui, H., Solomon, D. A., Gunawardena, R. W., Wang, Y., Knudsen, E. S.
(2003). Histone Deacetylation of RB-Responsive Promoters: Requisite for Specific Gene Repression but Dispensable for Cell Cycle Inhibition. Mol. Cell. Biol.
23: 7719-7731
[Abstract]
[Full Text]
-
Childs, K. S., Goodbourn, S.
(2003). Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res
31: 3016-3026
[Abstract]
[Full Text]
-
Balasenthil, S., Vadlamudi, R. K.
(2003). Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein. J. Biol. Chem.
278: 22119-22127
[Abstract]
[Full Text]
-
Fleischer, T. C., Yun, U. J., Ayer, D. E.
(2003). Identification and Characterization of Three New Components of the mSin3A Corepressor Complex. Mol. Cell. Biol.
23: 3456-3467
[Abstract]
[Full Text]
-
Zhang, Y., Woodford, N., Xia, X., Hamburger, A. W.
(2003). Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res
31: 2168-2177
[Abstract]
[Full Text]
-
Wen, Y.-D., Cress, W. D., Roy, A. L., Seto, E.
(2003). Histone Deacetylase 3 Binds to and Regulates the Multifunctional Transcription Factor TFII-I. J. Biol. Chem.
278: 1841-1847
[Abstract]
[Full Text]
-
Yochum, G. S., Ayer, D. E.
(2002). Role for the Mortality Factors MORF4, MRGX, and MRG15 in Transcriptional Repression via Associations with Pf1, mSin3A, and Transducin-Like Enhancer of Split. Mol. Cell. Biol.
22: 7868-7876
[Abstract]
[Full Text]
-
Zhang, W., Kone, B. C.
(2002). NF-kappa B inhibits transcription of the H+-K+-ATPase alpha 2-subunit gene: role of histone deacetylases. Am. J. Physiol. Renal Physiol.
283: F904-F911
[Abstract]
[Full Text]
-
Anderson, L. A., Perkins, N. D.
(2002). The Large Subunit of Replication Factor C Interacts with the Histone Deacetylase, HDAC1. J. Biol. Chem.
277: 29550-29554
[Abstract]
[Full Text]
-
Yu, Z., Zhang, W., Kone, B. C.
(2002). Histone Deacetylases Augment Cytokine Induction of the iNOS Gene. J. Am. Soc. Nephrol.
13: 2009-2017
[Abstract]
[Full Text]
-
Cook, J. L., Walker, T. A., Worthen, G. S., Radke, J. R.
(2002). Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. USA
99: 9966-9971
[Abstract]
[Full Text]
-
Sullivan, C. S., Pipas, J. M.
(2002). T Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and Tumorigenesis. Microbiol. Mol. Biol. Rev.
66: 179-202
[Abstract]
[Full Text]
-
Galasinski, S. C., Resing, K. A., Goodrich, J. A., Ahn, N. G.
(2002). Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions. J. Biol. Chem.
277: 19618-19626
[Abstract]
[Full Text]
-
Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J.-H., Catchpole, S., Watson, R. J., te Riele, H., Dynlacht, B. D.
(2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev.
16: 933-947
[Abstract]
[Full Text]
-
Wilsker, D., Patsialou, A., Dallas, P. B., Moran, E.
(2002). ARID Proteins: A Diverse Family of DNA Binding Proteins Implicated in the Control of Cell Growth, Differentiation, and Development. Cell Growth Differ.
13: 95-106
[Abstract]
[Full Text]
-
Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P., Reinberg, D.
(2002). Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1. Mol. Cell. Biol.
22: 835-848
[Abstract]
[Full Text]
-
Nicolas, E., Ait-Si-Ali, S., Trouche, D.
(2001). The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein. Nucleic Acids Res
29: 3131-3136
[Abstract]
[Full Text]
-
Kennedy, B. K., Liu, O. W., Dick, F. A., Dyson, N., Harlow, E., Vidal, M.
(2001). Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl. Acad. Sci. USA
10.1073/pnas.151240898v1
[Abstract]
[Full Text]
-
Lai, A., Kennedy, B. K., Barbie, D. A., Bertos, N. R., Yang, X. J., Theberge, M.-C., Tsai, S.-C., Seto, E., Zhang, Y., Kuzmichev, A., Lane, W. S., Reinberg, D., Harlow, E., Branton, P. E.
(2001). RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest. Mol. Cell. Biol.
21: 2918-2932
[Abstract]
[Full Text]
-
Ross, J. F., Näär, A., Cam, H., Gregory, R., Dynlacht, B. D.
(2001). Active repression and E2F inhibition by pRB are biochemically distinguishable. Genes Dev.
15: 392-397
[Abstract]
[Full Text]
-
Hirsch, H. A., Gu, L., Henry, R. W.
(2000). The Retinoblastoma Tumor Suppressor Protein Targets Distinct General Transcription Factors To Regulate RNA Polymerase III Gene Expression. Mol. Cell. Biol.
20: 9182-9191
[Abstract]
[Full Text]
-
Knudsen, K. E., Booth, D., Naderi, S., Sever-Chroneos, Z., Fribourg, A. F., Hunton, I. C., Feramisco, J. R., Wang, J. Y. J., Knudsen, E. S.
(2000). RB-Dependent S-Phase Response to DNA Damage. Mol. Cell. Biol.
20: 7751-7763
[Abstract]
[Full Text]
-
BURKE, L. J., BANIAHMAD, A.
(2000). Co-repressors 2000. FASEB J.
14: 1876-1888
[Abstract]
[Full Text]
-
Harbour, J. W., Dean, D. C.
(2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev.
14: 2393-2409
[Full Text]
-
Dallas, P. B., Pacchione, S., Wilsker, D., Bowrin, V., Kobayashi, R., Moran, E.
(2000). The Human SWI-SNF Complex Protein p270 Is an ARID Family Member with Non-Sequence-Specific DNA Binding Activity. Mol. Cell. Biol.
20: 3137-3146
[Abstract]
[Full Text]
-
Lee, S.-K., Kim, J.-H., Lee, Y. C., Cheong, J., Lee, J. W.
(2000). Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptors, as a Novel Transcriptional Corepressor Molecule of Activating Protein-1, Nuclear Factor-kappa B, and Serum Response Factor. J. Biol. Chem.
275: 12470-12474
[Abstract]
[Full Text]
-
Nicolas, E., Morales, V., Magnaghi-Jaulin, L., Harel-Bellan, A., Richard-Foy, H., Trouche, D.
(2000). RbAp48 Belongs to the Histone Deacetylase Complex That Associates with the Retinoblastoma Protein. J. Biol. Chem.
275: 9797-9804
[Abstract]
[Full Text]
-
Koipally, J., Georgopoulos, K.
(2000). Ikaros Interactions with CtBP Reveal a Repression Mechanism That Is Independent of Histone Deacetylase Activity. J. Biol. Chem.
275: 19594-19602
[Abstract]
[Full Text]
-
Jang, M. K., Goo, Y. H., Sohn, Y. C., Kim, Y. S., Lee, S.-K., Kang, H., Cheong, J., Lee, J. W.
(2001). Ca2+/Calmodulin-dependent Protein Kinase IV Stimulates Nuclear Factor-kappa B Transactivation via Phosphorylation of the p65 Subunit. J. Biol. Chem.
276: 20005-20010
[Abstract]
[Full Text]
-
Kennedy, B. K., Liu, O. W., Dick, F. A., Dyson, N., Harlow, E., Vidal, M.
(2001). Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl. Acad. Sci. USA
98: 8720-8725
[Abstract]
[Full Text]
-
Jiang, Z., Zacksenhaus, E.
(2002). Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. JCB
156: 185-198
[Abstract]
[Full Text]